CN113583467B - Nucleic acid fluorescent dye and preparation and application thereof - Google Patents

Nucleic acid fluorescent dye and preparation and application thereof Download PDF

Info

Publication number
CN113583467B
CN113583467B CN202110958363.6A CN202110958363A CN113583467B CN 113583467 B CN113583467 B CN 113583467B CN 202110958363 A CN202110958363 A CN 202110958363A CN 113583467 B CN113583467 B CN 113583467B
Authority
CN
China
Prior art keywords
compound
formula
fluorescent dye
sybr green
compound shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110958363.6A
Other languages
Chinese (zh)
Other versions
CN113583467A (en
Inventor
吴鹏
王彦莹
董真
李显明
杨琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Yueweilan Biotechnology Co ltd
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CN202110958363.6A priority Critical patent/CN113583467B/en
Publication of CN113583467A publication Critical patent/CN113583467A/en
Priority to PCT/CN2022/086524 priority patent/WO2023019983A1/en
Application granted granted Critical
Publication of CN113583467B publication Critical patent/CN113583467B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/04Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups one >CH- group, e.g. cyanines, isocyanines, pseudocyanines
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Electrochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to the field of fluorescent dyes, in particular to a novel nucleic acid fluorescent dye. The invention provides a fluorescent dye, which has a structural formula shown as a formula I, wherein AIs chloride ion, bromide ion or iodide ion. The invention carries out structural modification on the dye and provides another compound which has high sensitivity, good stability, easily obtained raw materials, simple synthesis, low sequence preference and small inhibition on PCR.
Figure DDA0003221176240000011

Description

Nucleic acid fluorescent dye and preparation and application thereof
Technical Field
The invention relates to the field of fluorescent dyes, in particular to a novel nucleic acid fluorescent dye.
Background
Fluorescent dye refers to a fluorescent substance that absorbs excitation light of a certain wavelength and emits light of a specific wavelength. The fluorescent dye is combined with a substance which does not emit fluorescence in a certain mode, and the chemical signal of the substance can be selectively converted into a fluorescent signal which is easy to be measured by an analysis instrument, so that the fluorescence detection of a specific target is realized. The detection method has the advantages of high sensitivity, good selectivity, capability of realizing visualization, real-time and nondestructive online monitoring in a living body and the like, and is widely applied to the field of biological analysis.
Nucleic acids (such as DNA and RNA) are carriers of genetic information of living bodies, and are often used as target analytes because of their large amount of information carried and their relatively stable intracellular content. Currently, fluorescence detection is the mainstream method for achieving nucleic acid analysis. In addition to labeling fluorescent dyes by covalent coupling, non-covalently bound "luminescent probes" (i.e., nucleic acid fluorescent dyes) are the most advantageous means for qualitative and quantitative analysis of nucleic acids. The fluorescent dye can be non-covalently combined with nucleic acid molecules, and the detection of the target nucleic acid molecules is realized through the huge difference of the self fluorescence properties before and after the combination. Such fluorescent dyes are widely used in various states such as solution, gel electrophoresis, nucleic acid analysis in cells and in the environment, and the like. Currently, there are many commercially available nucleic acid analysis fluorescent dyes, and among them, SYBR series dyes sold by Invitrogen corporation in the united states have excellent performance, and occupy most of the nucleic acid dye markets internationally.
Among the SYBR series of dyes, SYBR Green I is most widely used because it has low background, low toxicity and ultra-high sensitivity, and has been widely used in DNA routine analysis, DNA gel staining and as a nucleic acid dye dedicated to real-time quantitative pcr (qpcr) routine detection. However, SYBR Green I still has the following disadvantages:
(1) first, the dye applied to qPCR should have excellent chemical stability during PCR (105 ℃ C. -55 ℃ C.) and storage (-20 ℃ C. -4 ℃ C.). This requires that the dye and its complex with the nucleic acid molecule should have a certain thermal stability. In addition, Tris is often used as a buffer in qPCR, and is alkaline at low temperatures and slightly acidic at high temperatures. Therefore, the dye is required to have better acid-base stability. However, SYBR Green I does not have good stability under the above conditions;
(2) SYBR Green I has concentration-dependent inhibition effect on the PCR process, and the PCR process can be inhibited by using high-concentration dye;
(3) in routine analysis of nucleic acids (including qPCR and gel electrophoresis imaging), the sequence of dye-bound DNA should be favored to be low or absent. However, SYBR Green I has been reported to have a more significant A-T sequence preference (see Zipper H, Brunner H, Bernhagen J, Vitzthim F (2004) Nucleic Acids Res 32:103 e);
(4) according to the instructions provided by Invitrogen company, SYBR Green I can maintain good stability in DMSO and has poor stability in aqueous solution;
(5) in addition, although SYBR Green I has excellent fluorescence properties, its synthesis is extremely difficult and the yield is extremely low (less than 2%) according to the reverse synthesis analysis. In addition, the price of the raw materials is high, so that the price of SYBR Green I is high (the official selling price of stock solution with the specification of 10000x and 1mL is as high as about 1 ten thousand yuan), and the cost is high in practical application.
Although another dye, SYBR Safe, is also sold by Invitrogen, is less expensive and has low mutagenicity and may be used as a replacement for SYBR Green I, the water solubility and sensitivity of this alternative dye is less than ideal.
Disclosure of Invention
Aiming at the defects that the high-efficiency nucleic acid fluorescent dye (such as SYBR Green I) in the prior art is unstable, influences the PCR process due to high concentration, is difficult to synthesize and the like, the invention carries out structural modification on the dye and provides another compound which has high sensitivity, good stability, easily obtained raw materials, simple synthesis, low sequence preference and small PCR inhibition.
The technical scheme of the invention is as follows:
the first technical problem to be solved by the present invention is to provide a fluorescent dye, wherein the structural formula of the fluorescent dye is shown as formula I:
Figure BDA0003221176220000021
wherein A is-Is chloride ion, bromide ion or iodide ion.
The second technical problem to be solved by the present invention is to provide a preparation method of the above fluorescent dye, wherein the preparation method comprises: stirring and reacting the compound shown in the formula II and the monomer M in a solvent at room temperature for 6-24 hours to obtain a mixture, and then purifying the mixture to obtain the fluorescent dye shown in the formula I; wherein the monomer M is propylamine substituted by alkylamino.
Figure BDA0003221176220000031
Further, in the preparation method, the equivalent ratio of the compound shown in the formula II to the monomer M is 1: 1-1: 5.
Further, in the above production method, the monomer M is selected from: n, N-dimethyl-1, 3-diaminopropane or 3-diethylaminopropylamine.
Further, in the above preparation method, the solvent is ethanol or dichloromethane.
Further, in the reaction, the stirring time is 6 to 12 hours.
Further, the compound shown in the formula II is prepared by adopting the following method:
firstly, preparing the compound shown as the formula III
Figure BDA0003221176220000032
Then preparing the compound shown as the formula IV
Figure BDA0003221176220000033
Carrying out reflux reaction on a compound shown as a formula IV and phosphorus oxychloride in a solvent 1 at 65-85 ℃ to obtain a compound shown as a formula V
Figure BDA0003221176220000034
Wherein the solvent 1 is selected from at least one of acetonitrile, dichloroethane or dimethylformamide;
mixing a compound shown as a formula V and a compound shown as a formula III in a solvent 2 at an equivalent ratio of 1: 1-1: 3 at room temperature to obtain a compound shown as a formula II; the solvent 2 is ethanol or dichloromethane.
Further, the compound represented by the formula III is prepared by the following method: and (3) carrying out methylation reaction on the 2-methylmercaptobenzothiazole (with or without substituent groups) by using a methylation reagent (such as methyl iodide) to obtain the compound shown in the formula III.
Further, the compound shown in the formula IV is prepared by adopting the following method: preparing a compound shown in a formula IV by reacting 2-hydroxy-4-methylquinoline with iodobenzene or phenylboronic acid under the action of a catalyst; wherein the catalyst is copper acetate, potassium carbonate and copper powder.
The third technical problem to be solved by the present invention is to provide the use of the above fluorescent dye, which can be used in qPCR analysis or gel electrophoresis imaging.
The invention discovers for the first time that when the compound shown in the formula II and monomers such as N, N-dimethyl-1, 3-diaminopropane and the like are used as raw materials, a novel fluorescent dye (shown in the formula I) can be obtained only by stirring and reacting for 6-24 hours at room temperature, and the obtained fluorescent dye has higher response sensitivity of nucleic acid molecules compared with SYBR Green I, has higher thermal stability after being combined with nucleic acid, and can also improve the melting temperature of the nucleic acid molecules.
In addition, the benzothiazole and quinoline rings in the fluorescent dye are connected through a methine bond, and the single bond can rotate by itself, so that the dye molecule has strong intramolecular torsional charge transfer (TICT) in a free state. And moreover, due to the steric hindrance of the phenyl substituent and the alkylamino substituent on the quinoline ring, the compactness of dye molecule aggregation and accumulation is reduced, and the dye monomer almost has no fluorescence. When the fluorescent dye is combined with nucleic acid molecules, a methine bond connecting benzothiazole and quinoline rings is limited by the structure of the nucleic acid molecules and fixed, so that a conjugated structure is formed conveniently, and an enhanced fluorescent signal can be obtained.
The invention has the beneficial effects that:
1) the invention provides a design of a novel nucleic acid fluorescent dye, the dye is prepared from easily available raw materials, has multiple purchasing channels and low cost, and is simple in synthesis condition, easy to synthesize (the reaction can be completed in a short time at room temperature), and an intermediate product does not need to be additionally purified.
2) The fluorescent dye has excellent fluorescence performance and good stability, can be directly used in common PCR buffer solution (even pure water), and does not need to add a protective reagent; secondary structures that specifically recognize nucleic acid molecules; the dye has good thermal stability after reacting with nucleic acid molecules, and can effectively improve the melting temperature of the nucleic acid molecules.
3) The fluorescent dye obtained by the invention has low sequence preference on nucleic acid molecules and high sensitivity. The high-sensitivity detection of the nucleic acid molecules in solution, gel, cells and environment can be realized by detecting the fluorescent signal of the dye and nucleic acid molecule mixed system.
Description of the drawings:
FIG. 1 shows an absorption spectrum and a fluorescence spectrum of compound c in example 1 of the present invention.
FIG. 2 is a graph showing the relationship between the fluorescence intensity of the compound c (- ■ -), SYBR Green I (- ● -), and SYBR Green I analog (-. tangle-solidup. -) combined with double-stranded DNA of different concentrations and the corresponding double-stranded DNA concentration.
FIG. 3A is a graph of fluorescence intensity versus temperature for a double stranded DNA sample dsDNA-2 bound by compound c of the invention (solid line) and SYBR Green I (dashed line), and FIG. 3B is a melting curve for the corresponding dsDNA-2.
FIG. 4A is a graph of Harpin-1 fluorescence intensity versus temperature for a double stranded DNA sample combined with compound c of the present invention (solid line) and SYBR Green I (dashed line), and FIG. 4B is a melting curve for the corresponding Harpin-1.
FIG. 5A is a graph of dsDNA-3 fluorescence intensity versus temperature for a double stranded DNA sample with compound c of the invention (solid line) combined with SYBR Green I (dashed line), and FIG. 5B is a melting curve for the corresponding dsDNA-3.
FIG. 6 is a bar graph of the fluorescence response of the compound c of the present invention and SYBR Green I to double-stranded DNA with different d (A-T) contents.
FIG. 7 shows the qPCR fluorescent amplification curves of the compound c of the present invention at the concentrations of 0.5, 1, 2 and 4. mu. mol/L on the left, and SYBR Green I at the concentrations of 0.5(0.55X), 1(1.1X), 2(2.2X) and 4(4.4X) mu. mol/L on the right.
FIG. 8 shows the qPCR amplification curves of 1. mu. mol/L compound c of the present invention at primer concentrations of 50, 100, 200, and 300nmol/L, and FIG. 8 shows the qPCR amplification curves of 1. mu. mol/L (1.1X) SYBR Green I under the same conditions.
FIG. 9 is a graph showing the melting curves of the amplification products of 1. mu. mol/L compound c of the present invention at primer concentrations of 50, 100, 200 and 300nmol/L, and FIG. 8 is a graph showing the melting curves of the amplification products of 1. mu. mol/L (1.1X) SYBR Green I under the same conditions.
FIG. 10 is a graph comparing the effect of standard molecular weight DNA on gel imaging in the prestained mode, with 1. mu. mol/L (1.1X) SYBR Green I on the left and 1. mu. mol/L Compound c of the present invention on the right.
FIG. 11 is a graph comparing the effect of standard molecular weight DNA on gel imaging in post-staining mode, with 1. mu. mol/L (1.1X) SYBR Green I on the left and 1. mu. mol/L Compound c of the present invention on the right.
FIG. 12 is a graph showing a comparison of gel imaging effects of 1. mu. mol/L (1.1X) SYBR Green I and 1. mu. mol/L compound c of the present invention on PCR amplified products in the pre-staining mode on the left, and a graph showing a comparison of gel imaging effects in the post-staining mode on the right.
FIG. 13 is a graph showing the relationship between the fluorescence intensity detected at 55 ℃ and the number of thermal cycles performed by Compound c of the present invention.
FIG. 14A is a graph showing the relationship between the absorbance and the time change in pure water for the compound c (- ● -) and SYBR Green I (- ■ -) of the present invention, and FIG. 14B is a graph showing the relationship between the absorbance and the time change in Tris-HCl buffer solution for the compound c (- ● -) and SYBR Green I (- ■ -).
FIG. 15 synthetic route, cost comparison of compound c with SYBR Green I.
Detailed Description
The fluorescent dye can be prepared by adopting the following preparation method, and the preparation method comprises the following steps:
1) firstly, 2-methylmercaptobenzothiazole (with or without substituent groups) is methylated by a methylating agent (such as methyl iodide) to obtain a compound a
Figure BDA0003221176220000051
2) 2-hydroxy-4-methylquinoline and phenylboronic acid are catalyzed by copper acetate to obtain a compound b
Figure BDA0003221176220000061
3) Will be provided with
Figure BDA0003221176220000062
Mixing with phosphorus oxychloride to obtain the compound
Figure BDA0003221176220000063
Followed by reacting it with a compound
Figure BDA0003221176220000064
Mixing to obtain the compound
Figure BDA0003221176220000065
It reacts with N, N-dimethyl-1, 3-diaminopropane to give the final dye structure
Figure BDA0003221176220000066
The specific reaction formula is as follows:
Figure BDA0003221176220000071
the following further describes specific embodiments of the present invention in conjunction with examples, which are not intended to limit the invention thereto.
Example 1: preparation of the nucleic acid fluorescent dye of the present invention
The preparation method comprises the following steps:
1) the starting material, 2-methylmercaptobenzothiazole (1.5g, 8.3mmol, 1eq), was dissolved in 30mL of dry ethanol, and iodomethane (1.4g, 10mmol, 1.2eq) was added and reacted at 60 ℃ for 5 hours. After the reaction is finished, removing the solvent, washing for multiple times by using petroleum ether, and collecting an off-white solid product a by using a suction filtration method:
Figure BDA0003221176220000072
2) the raw material 2-hydroxy-4-methylquinoline (3.0g, 18.8mmol, 1eq), phenylboronic acid (2.3g, 18.8mmol, 1eq) and copper acetate (3.75g, 18.8mmol, 1eq) were dissolved in 150-mL dichloromethane, stirred at normal temperature for reaction for 48-96h, and then vacuum filtered. Extracting the filtrate with water for three times, collecting dichloromethane phase extractive solution, adding anhydrous calcium chloride, and drying for 1-2 hr. Concentrating the extract through SiO2Column purification gave a white solid b:
Figure BDA0003221176220000081
3) dissolve product b (100mg, 0.4mmol, 1eq) in 30mL acetonitrile, add phosphorus oxychloride (184mg, 1.2mmol, 3eq) under nitrogen atmosphereRefluxing at 60-85 deg.C for 12-24 hr. After the reaction is finished, cooling to room temperature, removing the solvent, dissolving the solvent and the compound a in 20-30mL of dichloromethane, and dropwise adding triethylamine at room temperature while stirring until no obvious white smoke is emitted. Stirring at room temperature for 5h, adding N, N-dimethyl-1, 3-diaminopropane (122mg, 1.2mmol, 3eq) as raw material dropwise, stirring at room temperature for 6-24h, concentrating the reaction mixture, passing through SiO2Purifying and separating by a column, and recrystallizing in dichloromethane and petroleum ether solvent to obtain the pure compound c.
Figure BDA0003221176220000082
Example 2: absorption spectrum and fluorescence spectrum of Compound c
The DNA samples were purchased from Biotechnology engineering (Shanghai) Inc. as two complementary oligonucleotide strands as shown in Table 1. DNA samples were purified by HPLC, and appropriate amounts of DNA were dissolved in TE buffer (pH 7.4, 10mmol/L Tris, 1mmol/L EDTA) according to the instructions to prepare corresponding concentrations of stock solutions, which were stored at 4 ℃. When in use, the two single strands (Pro-20 and Tar-20) with the same concentration are respectively added to form double-stranded DNA (dsDNA-1).
TABLE 1
Figure BDA0003221176220000091
The absorption spectrum of compound c (1. mu. mol/L) and the fluorescence emission spectrum after binding to dsDNA-1(20bp, 100nmol/L) were examined in TE buffer (shown in FIG. 1). The maximum absorption peak of compound c was 467nm (blue light), and the maximum fluorescence emission peak after binding to DNA was 505nm (green light). The compound c can be excited by a light source in the 400nm-500nm region and is matched with the optical channel of the qPCR and chemiluminescence imaging instrument which are mainstream on the market at present, which shows that the dye can be well adapted to the existing instrument.
Example 3: compound c for routine nucleic acid molecule quantification
The DNA samples were as in example 2.
Comparing compound c withSYBR Green I structure with N-H bond of compound c being closed by N-propyl
Figure BDA0003221176220000092
And methyl-blocked SYBR Green I analogs
Figure BDA0003221176220000093
Sensitivity of fluorescent response to different concentrations of nucleic acid molecules. In TE buffer with a volume of 200. mu.L and a concentration gradient of 5nmol/L, a mixture containing dsDNA-1 at a final concentration of 0-75nmol/L and compound c, SYBR Green I (0.55X) and SYBR Green I analog at a final concentration of 0.5. mu. mol/L was prepared. The fluorescence of the above mixture was measured using a fluorescence spectrometer Fluorolog-3(HORIBA, USA), and the detected fluorescence intensity was plotted against dsDNA-1 concentration as shown in FIG. 2. First, it can be seen that almost no fluorescent signal response was detected at a dsDNA-1 concentration of 0. As dsDNA concentration increases, fluorescence is linear to DNA concentration change over a range; at higher DNA concentrations, the response becomes nonlinear and the signal gradually becomes saturated. The slope of the ascending region in the linear range of change represents the sensitivity of the dye molecule to changes in DNA concentration. The results show that the sensitivity of the compound c response to 5nmol/L dsDNA-1 is significantly higher than SYBR Green I and the SYBR Green I analogues. Second, comparing the fluorescence intensity after saturation of binding of the same concentration of dye to dsDNA-1, the saturation fluorescence intensity of compound c was significantly higher than SYBR Green I and SYBR Green I analogs. The above results show that: compared with SYBR Green I and SYBR Green I analogues, the structure of the compound c has unique advantages, and the compound c has better binding capacity and higher detection sensitivity on DNA molecules.
Example 4: thermal stability of Compound c after binding to nucleic acid molecules
DNA samples were prepared as in example 2, and the DNA usage sequences are shown in Table 2.
TABLE 2
Figure BDA0003221176220000101
Protocol for thermal stability determination: samples containing 1. mu. mol/L of Compound c and 100nmol/L of DNA were mixed with 20. mu.L of Tris-HCl buffer (containing Mg at pH 8.3)2+) Holding at 95 ℃ for 15s followed by annealing; after incubation at 45 ℃ for 15min, StepOnePlus was usedTMThe qPCR instrument (ABI, usa) collects fluorescence signals (including 45 ℃) every +0.5 ℃; the temperature was raised to 95 ℃ and the incubation was carried out for 30s (the conditions for the thermal stability test of SYBR Green I were identical to those of Compound c). The fluorescence intensity of complexes formed between compound c and SYBR Green I and the different DNA samples described above was plotted against temperature (fig. 3A, 4A, and 5A), and the melting curves of the different DNA samples were plotted after taking the negative reciprocal of the slope at each point (fig. 3B, 4B, and 5B). The test result shows that: on one hand, the decrease speed of the fluorescence intensity (a relatively flat change area before the fluorescence intensity change is steeply reduced) in the temperature rise process after the compound c prepared in the embodiment 1 is combined with DNA is obviously slower than that of SYBR Green I, which shows that the thermal stability of a compound formed by the compound c and the DNA is obviously improved compared with that of the SYBR Green I. On the other hand, the corresponding abscissas (namely the melting temperature value, T) at the peak values of the melting curves of different DNA samples are comparedmValue), detected T of Compound cmThe value is also larger than SYBR Green I (shown in Table 3), and the compound c is proved to have good binding capacity and thermal stability in combination with DNA.
TABLE 3
Figure BDA0003221176220000102
Example 5: sequence Selectivity of Compound c
DNA samples were prepared as in example 2, and the DNA usage sequences are shown in Table 4.
TABLE 4
Figure BDA0003221176220000111
In a volume of 1mL and a pH of 7.4TE buffer, a DNA sample (AT-1) containing 10% adenine (A) -thymine (T) and a DNA sample (AT-2) containing 100% adenine (A) -thymine (T) were prepared AT a concentration of 100nmol/L, respectively, and a compound c was added thereto AT a final concentration of 1. mu. mol/L. After 10min incubation, the fluorescence intensity of the complex formation of compound c with two different DNA samples was determined using fluorescence spectrometer Fluorolog-3(HORIBA, usa), to which the sequence selectivity test conditions of SYBR Green I for comparison were kept consistent, the results are shown in fig. 6. The difference of the signal response of the compound c to the A-T sequence preference is only 15 percent and is obviously lower than SYBR Green I (40 percent), which indicates that the compound c has very low sequence preference to nucleic acid molecules and is suitable for the conventional detection of the nucleic acid molecules.
Example 6: application of compound c in qPCR amplification
Using the compound c prepared in example 1 as a fluorescent dye, StepOnePlus was usedTMqPCR instrument (ABI, usa) amplified the invA gene in salmonella. The primer sequences for qPCR amplification were as follows:
an upstream primer: 5'-TCCCTTTCCAGTACGCTTCG-3'
A downstream primer: 5'-TCTGGATGGTATGCCCGGTA-3'
Obtaining a template gene: salmonella DNA was extracted using a bacterial DNA extraction Kit (TIANAmp Bacteria DNA Kit, cat # DP302, TIANGEN, Beijing) according to the protocol.
qPCR conditions: the assay fluorescence intensity was set at 55 ℃ for 30s after holding at 95 ℃ for 20s, followed by extension at 72 ℃ for 30s for 30-40 cycles.
Selecting PCR kit (TaKaRa Taq)TMHS Low DNA, cat No.: R090A, TaKaRa, Japan) was prepared in a volume of 20. mu.L according to the instructions, including TaqTMHS Low DNA (2 ×), 10 μ L; 0.4. mu.L of each of the upstream primer and the downstream primer (containing DNA at final concentrations of 50nmol/L, 100nmol/L, 200nmol/L, and 300nmol/L, respectively); compound c or SYBR Green I for comparison, 2. mu.L (final concentrations of 0.5. mu. mol/L, 1. mu. mol/L, 2. mu. mol/L and 4. mu. mol/L, respectively); template gene, 2 μ L; sterile water was added to make up to a final volume of 20. mu.L.
1) Comparison of Signal intensity of Compound c with SYBR Green I in qPCR
The other conditions are kept consistent, the qPCR fluorescence amplification curve (fluorescence intensity versus cycle number) with only the concentration of the compound c being changed is shown in the left graph of FIG. 7, the SYBR Green I with different concentrations for comparison is shown in the right graph of FIG. 7, and the result shows that the change amplitude and the intensity of the fluorescence signal monitored by the compound c with different concentrations are higher than those of the SYBR Green I with the corresponding concentrations. In addition, at higher concentrations, SYBR Green I showed a more pronounced concentration-inhibiting effect, with C appearing compared to Compound C at the same concentrationTThe values lag (about 1 cycle). Experiments prove that compared with SYBR Green I, the compound c can be used for real-time amplification detection of nucleic acid in a larger concentration range, and can realize more sensitive detection.
2) Comparison of amplification curves of Compound c and SYBR Green I in qPCR
qPCR amplification curves with only change in primer concentration (ordinate. DELTA.R) keeping other conditions consistent (concentrations of Compound c and SYBR Green I are both 1. mu. mol/L)nNumber of cycles on abscissa) are shown in the upper graph of fig. 8, and SYBR Green I at different concentrations for comparison are shown in the lower graph of fig. 8. The results show that: the compound c synthesized by the invention has lower amplification background, and has no obvious concentration dependence compared with SYBR Green I at low primer concentration (50 nmol/L).
3) Compound c monitoring PCR amplicon melting temperature
SYBR Green I is reported to be an advantageous tool for monitoring the amplification product (i.e., the melting temperature of the amplicon) after completion of the qPCR amplification. Determination of the melting temperature of the amplicon provides information on the presence or absence of non-specific amplification and the identity of the amplicon. Accordingly, the melting curve of the amplicon monitored with compound c of the invention (upper panel in fig. 9) was also determined with varying primer concentrations to test the effect of monitoring the melting peak of the amplicon with compound c and compared to SYBR Green I (lower panel in fig. 9). First, the results of the two amplicon melting temperature tests have good correlation, and the measurement results are consistent. Secondly, the test baseline for compound c was lower compared to SYBR Green I, indicating that compound c provided in example 1 of the present invention enables detection of amplicon melting temperature.
Example 7: comparative experiment of gel staining effect
Gel staining is reported to be currently achieved mainly by two means: (1) before separation, adding the dye into the DNA mixed solution in advance, carrying out electrophoretic separation, and then carrying out fluorescence imaging, namely a pre-dyeing method; (2) after the electrophoresis separation of the DNA mixed solution, placing the gel into a fluorescent dye aqueous solution or buffer solution for soaking for a period of time, and then carrying out fluorescence imaging, namely a post-dyeing method; both modes of use are very common. The effect of the compound c prepared in example 1 (final concentration of 1. mu. mol/L) and SYBR Green I (final concentration of 1. mu. mol/L, 1.1X) on the pre-staining method (FIG. 10) and the post-staining method (FIG. 11), respectively, was compared, using DNA samples of 25-500bp DNA molecular weight standard Marker (cat # B600303, BBI, USA) according to the following instructions: 10ng, 5ng, 2ng, 1ng and 0.5 ng.
As can be seen from the comparison of the effect of the pre-dyeing method (FIG. 10) and the post-dyeing method (FIG. 11), the compound c prepared in the example 1 of the invention has the same effect as SYBR Green I in both dyeing modes, and compared with SYBR Green I in the pre-dyeing method, the compound c has no obvious tailing phenomenon in the dyeing result and has cleaner bands. In addition, the effect of compound c (final concentration of 1. mu. mol/L) compared with SYBR Green I (final concentration of 1. mu. mol/L, 1.1X) on the amplicon samples produced in example 6 was compared between the pre-staining and the post-staining (FIG. 12), and the results show that compound c is comparable to SYBR Green I in both pre-staining and post-staining in the practical application process. And more obviously, compared with the tailing phenomenon which is not generated by the SYBR Green I compound c pre-staining of an actual sample, the band is cleaner and clearer, and the different DNA fragments are more obviously distinguished.
Example 8: intrinsic stability of Compound c
The temperature range of qPCR is typically 55 ℃ to 105 ℃ and the qPCR reagents are stored at-20 ℃ to 4 ℃. In addition, the nucleic acid molecules need to be in an environment of pure aqueous solution or buffer solution. This requires that the dye molecules be stable in water or buffer and also stable at temperatures ranging from 55 ℃ to 105 ℃ and from-20 ℃ to 4 ℃.
1) Thermal stability
Tris-HCl buffer (Mg-containing) at pH 8.3 in a volume of 20. mu.L containing compound c at a final concentration of 10. mu. mol/L2+) In the system (a), after the compound c is subjected to 40 thermal cycles of 95 ℃ for 20s, 55 ℃ for 30s and 72 ℃ for 30s, as shown in FIG. 13, the compound c still keeps stable (the fluorescence intensity of the test is set at 55 ℃), the signal is not obviously reduced, and the durability of the compound c in qPCR is confirmed.
2) Stability in solution
Tris-HCl buffer (Mg-containing) pH 8.3 at 3mL volume containing compound c or SYBR Green I (1.1 ×) at a final concentration of 1 μmol/L2+) Or in a pure water system, the signal changes of the compound c and SYBR Green I at the maximum absorption wavelength of each compound c and SYBR Green I are monitored every 12-24h, wherein the pure water is shown as figure 14A, and the buffer solution is shown as figure 14B. The results show that: SYBR Green I in pure water is extremely unstable compared to buffering, which is consistent with the reported phenomenon that there is already nearly half of the molecular decomposition after 72 h; while compound c was more stable than SYBR Green I both in pure water and in buffer over the same time. More importantly, the compound c is very stable in pure water, which indicates that the storage environment of the compound c is not as harsh as SYBR Green I, and when a gel staining method adopts a post-staining method, the compound c can be directly prepared by using the pure water without additionally preparing a buffer solution, so that the use is more convenient.
Example 9: comparison of Synthesis costs of Compound c with SYBR Green I
Currently, SYBR Green I is the most widely applied dye in the market at present and has relatively high cost performance. However, according to the analysis of the SYBR Green I synthetic pathway (FIG. 15), the compound c has low requirements on reaction conditions, many sources for raw materials, no need of self-synthesis and low price (reagent price inquiry website: https:// www.bidepharm.com; https:// www.chemicalbook.com/product index. aspx); only three-step reaction is needed, intermediate product purification is not needed, heating is not needed in key step reaction, the yield is higher, and the experiment shows that the performance of the compound c is superior to that of SYBR Green I.
More importantly, in practical nucleic acid molecule detection, dye cost is the most important ring affecting the overall cost of the assay. Although SYBR Green I is a highly sensitive nucleic acid dye, the price is high, the official price is about 1 ten thousand yuan (1 mL) (10000x), and the cost of the reagent per se is too high, particularly when the SYBR Green I is put into large-scale nucleic acid detection and gel electrophoresis imaging. As proved by a gel staining experiment in example 7, the compound c has the staining effect equivalent to that of SYBR Green I and even has better effect, but the synthesis cost of the compound c is far lower than that of the SYBR Green I. This indicates that compound c can greatly reduce the production cost matched therewith while maintaining high sensitivity.
SEQUENCE LISTING
<110> Sichuan university
<120> nucleic acid fluorescent dye and preparation and application thereof
<130> 2021.8.2
<160> 13
<170> PatentIn version 3.5
<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
acagacacct acagacacct 20
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
aggtgtctgt aggtgtctgt 20
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
ctctcagtct gcatctcact 20
<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
agtgagatgc agactgagag 20
<210> 5
<211> 60
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
acagacacct acagacacct acagacacct acagacacct acagacacct acagacacct 60
<210> 6
<211> 60
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
aggtgtctgt aggtgtctgt aggtgtctgt aggtgtctgt aggtgtctgt aggtgtctgt 60
<210> 7
<211> 48
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
gcagacacct acagacacct aaaaaaatag gtgtctgtag gtgtctgc 48
<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
tccgcgcgcc cgggccgcca 20
<210> 9
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
tggcggcccg ggcgcgcgga 20
<210> 10
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
aaaaaaaaaa aaaaaaaaaa 20
<210> 11
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
tttttttttt tttttttttt 20
<210> 12
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
tccctttcca gtacgcttcg 20
<210> 13
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
tctggatggt atgcccggta 20

Claims (10)

1. A fluorescent dye, wherein the structural formula of the fluorescent dye is shown as formula I:
Figure FDA0003550831810000011
wherein A is-Is chloride ion, bromide ion or iodide ion.
2. The method of preparing a fluorescent dye according to claim 1, wherein the method comprises: stirring and reacting the compound shown in the formula II and the monomer M in a solvent at room temperature for 6-24 hours to obtain a mixture, and then purifying the mixture to obtain the fluorescent dye shown in the formula I; wherein the monomer M is propylamine substituted by alkylamino;
Figure FDA0003550831810000012
3. the method of claim 2, wherein the equivalent ratio of the compound of formula II to monomer M is 1: 1-1: 5.
4. the method of claim 2 or 3, wherein the monomer M is selected from the group consisting of: n, N-dimethyl-1, 3-diaminopropane or 3-diethylaminopropylamine.
5. The method of claim 2 or 3, wherein the solvent is ethanol or dichloromethane.
6. The method for preparing a fluorescent dye according to claim 2 or 3, wherein the stirring time is 6 to 12 hours.
7. The method for preparing a fluorescent dye according to claim 2 or 3, wherein the compound represented by the formula II is prepared by the following method:
firstly, preparing the compound shown as the formula III
Figure FDA0003550831810000021
Then preparing the compound shown as the formula IV
Figure FDA0003550831810000022
Carrying out reflux reaction on a compound shown as a formula IV and phosphorus oxychloride in a solvent 1 at 65-85 ℃ to obtain a compound shown as a formula V
Figure FDA0003550831810000023
Wherein the solvent 1 is selected from at least one of acetonitrile, dichloroethane or dimethylformamide;
in a solvent 2, a compound shown as a formula V and a compound shown as a formula III are mixed in an equivalent ratio of 1: 1-1: 3 mixing at room temperature to obtain a compound shown as a formula II; the solvent 2 is ethanol or dichloromethane.
8. The method of claim 7, wherein the compound of formula III is prepared by the following method: and (3) carrying out methylation reaction on the 2-methylmercaptobenzothiazole by using a methylation reagent to obtain the compound shown in the formula III.
9. The method of claim 7, wherein the compound of formula iv is prepared by the following method: preparing a compound shown in a formula IV by reacting 2-hydroxy-4-methylquinoline with iodobenzene or phenylboronic acid under the action of a catalyst; wherein the catalyst is copper acetate or copper powder.
10. Use of a fluorescent dye in qPCR analysis or gel electrophoresis imaging, the fluorescent dye being as defined in claim 1 or prepared by the method of any one of claims 2 to 9.
CN202110958363.6A 2021-08-20 2021-08-20 Nucleic acid fluorescent dye and preparation and application thereof Active CN113583467B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202110958363.6A CN113583467B (en) 2021-08-20 2021-08-20 Nucleic acid fluorescent dye and preparation and application thereof
PCT/CN2022/086524 WO2023019983A1 (en) 2021-08-20 2022-04-13 Nucleic acid fluorescent dye and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110958363.6A CN113583467B (en) 2021-08-20 2021-08-20 Nucleic acid fluorescent dye and preparation and application thereof

Publications (2)

Publication Number Publication Date
CN113583467A CN113583467A (en) 2021-11-02
CN113583467B true CN113583467B (en) 2022-04-26

Family

ID=78238630

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110958363.6A Active CN113583467B (en) 2021-08-20 2021-08-20 Nucleic acid fluorescent dye and preparation and application thereof

Country Status (2)

Country Link
CN (1) CN113583467B (en)
WO (1) WO2023019983A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113583467B (en) * 2021-08-20 2022-04-26 四川大学 Nucleic acid fluorescent dye and preparation and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133343B2 (en) * 2009-11-30 2015-09-15 Enzo Biochem, Inc. Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
CN102115610B (en) * 2010-01-05 2014-07-02 大连理工大学 Fluorescent dye, preparation method and application thereof
US9682970B2 (en) * 2012-06-29 2017-06-20 Biotium, Inc. Fluorescent compounds and uses thereof
CN104650609B (en) * 2013-11-22 2017-04-26 沈阳药科大学 Thiazol orange derivative, manufacturing method and application of thiazol orange derivative used as double helix nucleic acid fluorescence molecular probe
CN106147753B (en) * 2015-04-24 2020-03-10 广东工业大学 Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe
WO2021092795A1 (en) * 2019-11-13 2021-05-20 李峰 Nucleic acid detection method and device
CN113201583B (en) * 2021-04-29 2022-02-08 国科宁波生命与健康产业研究院 Method for synthesizing nucleic acid under constant temperature condition, kit and application
CN113583467B (en) * 2021-08-20 2022-04-26 四川大学 Nucleic acid fluorescent dye and preparation and application thereof

Also Published As

Publication number Publication date
CN113583467A (en) 2021-11-02
WO2023019983A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
JP4602956B2 (en) Probes labeled with energy transfer linked dyes
US9068948B2 (en) Processes for detection of nucleic acids
EP1368489B1 (en) Asynchronous primed pcr
US8357793B2 (en) Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds
EP0643140A1 (en) Determination of nucleic acid by PCR, measurement of number of microbial cells, genes, or gene-copies by PCR, and measuring-kit employed for the same
WO2005098036A1 (en) Oligonucleotide for detecting target dna or rna
TWI622580B (en) Polymethine compounds and their use as fluorescent labels
EP1110088B1 (en) Energy transfer dyes
CN113583467B (en) Nucleic acid fluorescent dye and preparation and application thereof
Wang et al. Homogeneous Time-Resolved Fluorescence DNA Hybridization Assay by DNA-Mediated Formation of an EDTA–Eu (III)–β-Diketonate Ternary Complex
US20190048401A1 (en) Optimized real-time nucleic acid detection processes
JP4265134B2 (en) Novel fluorescent dye and method for measuring nucleic acid
EP1223226B1 (en) Novel fluorescent dye and method of measuring nucleic acid
Bai et al. A new phosphoramidite enables orthogonal double labelling to form combination oligonucleotide probes
JPH08503604A (en) Green fluorescently labeled nucleotide for use in a probe
CN115724835A (en) Nucleic acid dye with low concentration effect and high fluorescence effect and preparation and application thereof
US6967250B1 (en) Energy transfer dyes
CN115060694A (en) Fluorescence method for detecting double-stranded DNA forming process
CN110642806A (en) Double-stranded DNA (deoxyribonucleic acid) combined fluorescent dye as well as preparation and application thereof
AU2001268235B2 (en) Asynchronous primed PCR
AU2001268235A1 (en) Asynchronous primed PCR

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20230818

Address after: No. 577, 5th Floor, Building 1, No. 1388, Middle Section of Tianfu Avenue, Chengdu High tech Zone, China (Sichuan) Pilot Free Trade Zone, Chengdu City, Sichuan Province, 610000

Patentee after: Chengdu Yueweilan Biotechnology Co.,Ltd.

Address before: 610065, No. 24, south section of Ring Road, Sichuan, Chengdu

Patentee before: SICHUAN University

TR01 Transfer of patent right